A Clinical and Laboratory Evaluation of Methionine Cycle-Transsulfuration and Androgen Pathway Markers in Children with Autistic Disorders

Background/Aims: The prevalence of autism spectrum disorders (ASDs) is 1 in 300 children in the US. ASDs are characterized by impairments in social relatedness and communication, repetitive behaviors, abnormal movement patterns, and sensory dysfunction. Pre-pubertal age children with ASDs were assessed for metabolites in the methionine cycle-transsulfuration and androgen pathways, and for present physical development/behaviors indicative of hyperandrogenicity. Methods: The Institutional Review Board of the Institute for Chronic Illnesses (Office for Human Research Protections, US Department of Health and Human Services IRB number: IRB00005375) approved the present study. Sixteen consecutive pre-pubertal age children (≤11 years old; mean ± SD: 5.9 ± 2.1 years old) with previously diagnosed ASDs that presented to the Genetic Centers of America for outpatient care were evaluated. Results: Significantly (p < 0.01) increased levels of serum/plasma dehydroepiandrosterone and serum total testosterone relative to the age- and sex-specific normal laboratory reference ranges were observed. Conversely, serum follicle-stimulating hormone levels were significantly (p < 0.01) decreased. Plasma-reduced glutathione (p < 0.01), plasma cysteine (p < 0.01), plasma methionine (p < 0.01), serum cystathionine (p < 0.05), and serum homocysteine (p < 0.01) were all significantly decreased. Conclusion: The results suggest a possible cyclical interaction between the methionine cycle-transsulfuration and androgen pathways in some children with ASDs.

[1]  J. Carroll,et al.  Studies on a 3β3-hydroxysteroid sulphotransferase from rat liver , 1976 .

[2]  R. A. Ryan,et al.  Studies on a 3beta-hydroxysteroid sulphotransferase from rat liver. , 1976, Biochimica et biophysica acta.

[3]  P. Roubertoux,et al.  Androgenic activity in autism. , 1997, The American journal of psychiatry.

[4]  E. Giltay,et al.  Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. , 1998, The Journal of clinical endocrinology and metabolism.

[5]  P. Donohoue,et al.  Premature sexual development in individuals with neurodevelopmental disabilities , 1999, Developmental medicine and child neurology.

[6]  P. Decouflé,et al.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. , 2001, Pediatrics.

[7]  S. Bölte,et al.  The Relation Between General Cognitive Level and Adaptive Behavior Domains in Individuals with Autism with and Without Co-Morbid Mental Retardation , 2002, Child psychiatry and human development.

[8]  C. McDougle,et al.  Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. , 2003, Pediatrics.

[9]  J. F. White,et al.  Intestinal Pathophysiology in Autism , 2003, Experimental biology and medicine.

[10]  M. Hill,et al.  Plasma Thiols and Androgen Levels in Polycystic Ovary Syndrome , 2003, Clinical chemistry and laboratory medicine.

[11]  J. Geleijnse,et al.  Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals. , 2003, Atherosclerosis.

[12]  Inge-Marie Eigsti,et al.  A systems neuroscience approach to autism: biological, cognitive, and clinical perspectives. , 2003, Mental retardation and developmental disabilities research reviews.

[13]  David W Gaylor,et al.  Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.

[14]  G. Dawson,et al.  Validation of the phenomenon of autistic regression using home videotapes. , 2005, Archives of general psychiatry.

[15]  Rebecca C. Knickmeyer,et al.  Sex Differences in the Brain: Implications for Explaining Autism , 2005, Science.

[16]  D. Geier,et al.  The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. , 2005, Medical hypotheses.

[17]  Abraham Weizman,et al.  Lowered DHEA-S plasma levels in adult individuals with autistic disorder , 2005, European Neuropsychopharmacology.

[18]  B. Nemeș,et al.  High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. , 2006, Life sciences.